Our partners and collaborators
We partner with exceptional leaders across all stages to build transformative heart failure technology. Get in touch to discuss how we could work together.
World renowned investors
We have been invested in world renowned companies, including Blue Cross, Optum Ventures, Google Ventures, and Oxford Sciences Innovation have invested $55 million into Ultromics to tackle the global burden of CVD.
Setting new standards in artificial intelligence
We are part of the AI taskforce led by the American Society of Echocardiography (ASE) which sets principles and guidance for the use of AI in echocardiography. Our technology is regulated, patented and trained on a one-of-a-kind outcomes database, which has been peer viewed and tested in real clinical settings.
